Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PVLA

Palvella Therapeutics Inc

148.21

Jun 26 • 04:00PM ET +12.01 (8.82%)

Healthcare Biotechnology USA Mid NASD

Peers: KYMR MANE ORKA RYTM KRYS NUVL BMRN INCY AXSM NBIX

| Held by: XBI VTI IWM VXF IWO VTWO VHT VFMO IWC LFSC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.17	Insider Own	29.42%	Shs Outstand	15.74M	Perf Week	31.04%
Market Cap	2.13B	Forward P/E	-	EPS next Y	-6.43	Insider Trans	-0.45%	Shs Float	10.13M	Perf Month	27.48%
Enterprise Value	1.88B	PEG	-	EPS next Q	-1.16	Inst Own	83.65%	Short Float	20.50%	Perf Quarter	26.02%
Income	-49.30M	P/S	-	EPS this Y	-49.81%	Inst Trans	32.60%	Short Ratio	8.43	Perf Half Y	47.81%
Sales	0.00M	P/B	10.04	EPS next Y	-15.73%	ROA	-28.73%	Short Interest	2.08M	Perf YTD	41.60%
Book/sh	14.76	P/C	8.12	EPS next 5Y	12.81%	ROE	-34.25%	52W High	151.18 -1.96%	Perf Year	618.77%
Cash/sh	18.26	P/FCF	-	EPS past 3/5Y	53.08% 41.62%	ROIC	-106.76%	52W Low	20.35 628.30%	Perf 3Y	884.39%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.35% 6.59%	Perf 5Y	-53.68%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	66.94%	Oper. Margin	-	ATR (14)	7.91	Perf 10Y	11.60%
Dividend Ex-Date	-	Quick Ratio	5.20	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	72.86	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	28.88	EPS Q/Q	-62.12%	SMA20	28.56%	Beta	-0.18	Target Price	229.00
Payout	-	Debt/Eq	0.08	Sales Q/Q	-	SMA50	24.21%	Rel Volume	4.76	Prev Close	136.20
Employees	29	LT Debt/Eq	0.08	Earnings	May 07 BMO	SMA200	48.84%	Avg Volume	246.30K	Price	148.21
IPO	Jan 02, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-28.34% -	Trades		Volume	1,172,144	Change	8.82%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)